BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36250843)

  • 41. Expression of the Fas antigen on primary human leukemia cells.
    Munker R; Lübbert M; Yonehara S; Tuchnitz A; Mertelsmann R; Wilmanns W
    Ann Hematol; 1995 Jan; 70(1):15-7. PubMed ID: 7530054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
    Liu L; Fu Q; Zhang D; Chen D; Wang F; Guo R; Xie X; Jiang Z; Yu J; Li Y
    Hemoglobin; 2023 Nov; 47(2):31-35. PubMed ID: 37161838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
    Liu K; Hu J; Wang X; Li L
    J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.
    Ohler L; Geissler K; Hinterberger W
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):537-46. PubMed ID: 13677271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
    Koh H; Nakamae H; Hagihara K; Nakane T; Manabe M; Hayashi Y; Nishimoto M; Umemoto Y; Nakamae M; Hirose A; Inoue E; Inoue A; Yoshida M; Bingo M; Okamura H; Aimoto R; Aimoto M; Terada Y; Koh KR; Yamane T; Ohsawa M; Hino M
    J Exp Clin Cancer Res; 2011 Apr; 30(1):36. PubMed ID: 21477348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia.
    Giles FJ; Cortes JE; Baker SD; Thomas DA; O'Brien S; Smith TL; Beran M; Bivins C; Jolivet J; Kantarjian HM
    J Clin Oncol; 2001 Feb; 19(3):762-71. PubMed ID: 11157029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.
    Dinmohamed AG; van Norden Y; Visser O; Posthuma EF; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Leuk Res; 2015 Feb; 39(2):177-82. PubMed ID: 25533930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indirect viscosimetric method is less accurate than ektacytometry for the measurement of red blood cell deformability.
    Vent-Schmidt J; Waltz X; Pichon A; Hardy-Dessources MD; Romana M; Connes P
    Clin Hemorheol Microcirc; 2015; 59(2):115-21. PubMed ID: 23594502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
    Hsu KC; Keever-Taylor CA; Wilton A; Pinto C; Heller G; Arkun K; O'Reilly RJ; Horowitz MM; Dupont B
    Blood; 2005 Jun; 105(12):4878-84. PubMed ID: 15731175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of differential mitotic cell age in bone marrow CD34(+) cells from patients with myelodysplastic syndrome and acute leukemia by analysis of an epigenetic molecular clock DNA signature.
    Mossner M; Hopfer O; Nowak D; Baldus CD; Neumann U; Kmetsch A; Benlasfer O; John T; Perka C; Thiel E; Hofmann WK
    Exp Hematol; 2010 Aug; 38(8):661-5. PubMed ID: 20399247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
    Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
    Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
    Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.
    Ma W; Kantarjian H; Zhang K; Zhang X; Wang X; Chen C; Donahue AC; Zhang Z; Yeh CH; O'Brien S; Garcia-Manero G; Caporaso N; Landgren O; Albitar M
    BMC Med Genet; 2010 Nov; 11():163. PubMed ID: 21078205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
    Jabbour E; Garcia-Manero G; Cortes J; Ravandi F; Plunkett W; Gandhi V; Faderl S; O'Brien S; Borthakur G; Kadia T; Burger J; Konopleva M; Brandt M; Huang X; Kantarjian H
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):244-51. PubMed ID: 22534616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of rearrangement within the breakpoint cluster region of chromosome 22 in the diagnosis of chronic myeloid leukemia.
    Hutchins C; Casey G; White D; Moore S; Rudzki Z; Kimber R
    Aust N Z J Med; 1989 Oct; 19(5):443-8. PubMed ID: 2590093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
    Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
    Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnosis of adult leukemia].
    Kuraishi Y; Takasaki N; Ogawa K
    Gan No Rinsho; 1989 Jan; Spec No():560-9. PubMed ID: 2915500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.